top of page

Neuro-Oncology Advances Publishes About Neosoma's Technology


Jan 20, 2023

Neosoma HGG's (NS-HGlio) Technology and Development was Recently Published in Neuro-Oncology Advances

We are proud to announce that the technology and development of Neosoma HGG (NS-HGlio) was recently published in Neuro-Oncology Advances, a high-impact peer-reviewed journal of the Society of Neuro-Oncology.

Aly Abayazeed, MD, Neosoma's Co-Founder and Chief Medical Officer, served as primary author on the paper, with contributions from multiple additional authors.

Our commitment to quality research and peer reviewed publications ensures transparency and confidence in our technologies.

Neosoma is incredibly grateful to our patients and everyone involved in this project, without whose hard work and dedication this publication would not have been possible.

Read the full paper here.

bottom of page